| Filed On | Filing |
|---|---|
| 21 Aug 2026 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of DiamiR Biosciences Corp. (the “Company”) as of May 31, 2026 and 2025, the related consolidated statements of operations, stockholders’ deficit and cash flows for each of the... |
Loading...
